» Articles » PMID: 38451818

Hepatic Snai1 and Snai2 Promote Liver Regeneration and Suppress Liver Fibrosis in Mice

Overview
Journal Cell Rep
Publisher Cell Press
Date 2024 Mar 7
PMID 38451818
Authors
Affiliations
Soon will be listed here.
Abstract

Liver injury stimulates hepatocyte replication and hepatic stellate cell (HSC) activation, thereby driving liver regeneration. Aberrant HSC activation induces liver fibrosis. However, mechanisms underlying liver regeneration and fibrosis remain poorly understood. Here, we identify hepatic Snai1 and Snai2 as important transcriptional regulators for liver regeneration and fibrosis. Partial hepatectomy or CCl4 treatment increases occupancies of Snai1 and Snai2 on cyclin A2 and D1 promoters in the liver. Snai1 and Snai2 in turn increase promoter H3K27 acetylation and cyclin A2/D1 expressions. Hepatocyte-specific deletion of both Snai1 and Snai2, but not one alone, suppresses liver cyclin A2/D1 expression and regenerative hepatocyte proliferation after hepatectomy or CCl4 treatments but augments CCl4-stimulated HSC activation and liver fibrosis. Conversely, Snai2 overexpression in the liver enhances hepatocyte replication and suppresses liver fibrosis after CCl4 treatment. These results suggest that hepatic Snai1 and Snai2 directly promote, via histone modifications, reparative hepatocyte replication and indirectly inhibit liver fibrosis.

Citing Articles

Sexually Dimorphic Effects of CYP2B6 in the Development of Fasting-Mediated Steatosis in Mice: Role of the Oxylipin Products 9-HODE and 9-HOTrE.

Eccles-Miller J, Johnson T, Baldwin W Biomedicines. 2025; 13(2).

PMID: 40002708 PMC: 11853041. DOI: 10.3390/biomedicines13020295.


Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension.

Li Y, Zhu B, Shi K, Lu Y, Zeng X, Li Y Front Med (Lausanne). 2025; 12:1515400.

PMID: 39958826 PMC: 11825794. DOI: 10.3389/fmed.2025.1515400.


Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.

Ma X, Huang T, Chen X, Li Q, Liao M, Fu L Signal Transduct Target Ther. 2025; 10(1):63.

PMID: 39920130 PMC: 11806117. DOI: 10.1038/s41392-024-02104-8.

References
1.
Yao C, Su L, Shan J, Zhu C, Liu L, Liu C . IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer. Stem Cells. 2016; 34(4):820-31. DOI: 10.1002/stem.2320. View

2.
Merlen G, Gentric G, Celton-Morizur S, Foretz M, Guidotti J, Fauveau V . AMPKα1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expression. J Hepatol. 2013; 60(1):152-9. DOI: 10.1016/j.jhep.2013.08.025. View

3.
Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millan C, Lozano J . Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology. 2012; 55(6):1931-41. DOI: 10.1002/hep.25614. View

4.
Inoue H, Takahashi H, Hashimura M, Eshima K, Akiya M, Matsumoto T . Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma. BMC Cancer. 2016; 16:53. PMC: 4739330. DOI: 10.1186/s12885-016-2090-y. View

5.
Zhou Y, Jiang L, Rui L . Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J Biol Chem. 2009; 284(17):11152-9. PMC: 2670120. DOI: 10.1074/jbc.M900754200. View